Purchases and Sales Made in Q3 2024 in Lexaria Bioscience Corp. (LEXX)
This table provides information about the institutional ownership of Lexaria Bioscience Corp. (LEXX) during Q3 2024. The information is specifically focused on institutions that hold shares of Lexaria Bioscience Corp..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
35.6K+ 31.02% |
$91.9K - $146K
|
150K
$266K
|
|
Nov 13, 2024
Q3 2024
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
15.4K+ 16.49% |
$39.8K - $63.1K
|
109K
$193K
|
|
Nov 13, 2024
Q3 2024
|
Bank Of Montreal
Toronto, A6 |
BUY
|
- |
14KNew |
$36.1K - $57.3K
|
14K
$24.8K
|
|
Nov 14, 2024
Q3 2024
|
High Tower Advisors, LLC
Chicago, IL |
BUY
|
- |
13KNew |
$33.6K - $53.3K
|
13K
$23.1K
|
|
Nov 12, 2024
Q3 2024
|
Hrt Financial LP
New York, NY |
BUY
|
- |
10.3KNew |
$26.5K - $42K
|
10.3K
$18.2K
|
|
Nov 14, 2024
Q3 2024
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
6.02K+ 47.8% |
$15.5K - $24.6K
|
18.6K
$33K
|
|
Oct 10, 2024
Q3 2024
|
Sound Income Strategies, LLC
|
BUY
|
- |
22New |
$56.8 - $90
|
22
$38.9
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
19+ 19.79% |
$49 - $77.7
|
115
$204
|
|
Nov 12, 2024
Q3 2024
|
Northwestern Mutual Wealth Management CO
|
BUY
|
- |
9New |
$23.2 - $36.8
|
9
$15.9
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 13, 2024
Q3 2024
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-800- 24.24% |
$2.06K - $3.27K
|
2.5K
$4.43K
|
|
Nov 14, 2024
Q3 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-2.03K- 60.12% |
$5.23K - $8.29K
|
1.34K
$2.38K
|
|
Oct 18, 2024
Q3 2024
|
Raymond James Financial Services Advisors, Inc.
St. Petersburg, FL |
SELL
|
- |
-3.9K- 7.99% |
$10.1K - $16K
|
44.9K
$79.5K
|
|
Jan 28, 2025
Q3 2024
|
Byrne Asset Management LLC
|
SELL
|
- |
-7.4K- 56.92% |
$19.1K - $30.3K
|
5.6K
$9.91K
|
|
Jan 29, 2025
Q3 2024
|
Byrne Asset Management LLC
|
SELL
|
- |
-7.4K- 56.92% |
$19.1K - $30.3K
|
5.6K
$9.91K
|
|
Nov 14, 2024
Q3 2024
|
Invenomic Capital Management LP
Boston, MA |
SELL
|
- |
-37.8K- 7.36% |
$97.5K - $155K
|
476K
$842K
|